CTX211 Trademark

Trademark Overview


On Monday, January 8, 2024, a trademark application was filed for CTX211 with the United States Patent and Trademark Office. The USPTO has given the CTX211 trademark a serial number of 98347437. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, November 21, 2024. This trademark is owned by CRISPR Therapeutics AG. The CTX211 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
ctx211

General Information


Serial Number98347437
Word MarkCTX211
Filing DateMonday, January 8, 2024
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCTX TWO HUNDRED ELEVEN
Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
Pseudo MarkCTX TWO ONE ONE
Goods and ServicesGene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH

Trademark Events


Event DateEvent Description
Monday, January 8, 2024NEW APPLICATION ENTERED
Friday, April 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER
Thursday, May 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 9, 2024NON-FINAL ACTION E-MAILED
Thursday, May 9, 2024NON-FINAL ACTION WRITTEN
Monday, August 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, August 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, November 21, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, November 21, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE